A woman, who organised a series of charity music festivals after being diagnosed with ovarian cancer, is to launch a support ...

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...

Christiane Amanpour has been diagnosed with cancer again. The 67-year-old chief international anchor for CNN shared the news ...

CNN’s Christiane Amanpour revealed that her ovarian cancer has returned. The international journalist explained that although ...

Survivors like Coach Jean Varas join caregivers and community for a heartfelt Saturday stroll to fund vital support—no early ...

After a month off the air, the veteran journalist disclosed that the disease had returned in what doctors described as a ...

A label expansion for Keytruda in platinum-resistant ovarian cancer would further entrench MSD’s dominance in the PD-1 space.

A CNN anchor has revealed their ovarian cancer has returned for the time, RadarOnline.com can reveal. They made the big ...

Veteran journalist Christiane Amanpour, who shared her ovarian cancer diagnosis in 2021, revealed she's battling the disease ...

BERLIN -- After multiple failed attempts, an immune checkpoint inhibitor has broken through and landed a significant overall survival (OS) benefit in ovarian cancer, phase III study results showed.

When pembrolizumab was added to paclitaxel with or without bevacizumab in platinum-resistant ovarian cancer, significant improvements in progression-free and overall survival were seen.

LAWRENCEVILLE, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it will ...